These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20302582)

  • 1. High-concentration (20 μg g⁻¹ ) tacalcitol ointment in the treatment of facial psoriasis: an 8-week open-label clinical trial.
    Choi JW; Choi JW; Kwon IH; Youn JI
    Br J Dermatol; 2010 Jun; 162(6):1359-64. PubMed ID: 20302582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tacalcitol in the treatment of psoriasis vulgaris: the Spanish experience.
    Lecha M; Mirada A; López S; Artés M;
    J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):414-7. PubMed ID: 15987284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-concentration (20 mug/g) tacalcitol ointment therapy on refractory psoriasis vulgaris with low response to topical corticosteroids.
    Katayama I; Ohkawara A; Ohkido M; Harada S; Tamaki K; Nakagawa H; Hori Y; Nishiyama S
    Eur J Dermatol; 2002; 12(6):553-7. PubMed ID: 12459526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term safety and efficacy of high-concentration (20 microg/g) tacalcitol ointment in psoriasis vulgaris.
    Miyachi Y; Ohkawara A; Ohkido M; Harada S; Tamaki K; Nakagawa H; Hori Y; Nishiyama S
    Eur J Dermatol; 2002; 12(5):463-8. PubMed ID: 12370136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical tacalcitol ointment can be a good therapeutic choice in erythromelanosis follicularis faciei et colli.
    Kim WJ; Song M; Ko HC; Kim BS; Kim MB
    J Am Acad Dermatol; 2012 Aug; 67(2):320-1. PubMed ID: 22794809
    [No Abstract]   [Full Text] [Related]  

  • 6. Pimecrolimus 1% cream in the treatment of facial psoriasis: a 16-week open-label study.
    Jacobi A; Braeutigam M; Mahler V; Schultz E; Hertl M
    Dermatology; 2008; 216(2):133-6. PubMed ID: 18216475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profile of clinical efficacy and safety of topical tacalcitol.
    Leone G; Pacifico A
    Acta Biomed; 2005 Apr; 76(1):13-9. PubMed ID: 16116820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four cases of sebopsoriasis or seborrheic dermatitis of the face and scalp successfully treated with 1a-24 (R)-dihydroxycholecalciferol (tacalcitol) cream.
    Nakayama J
    Eur J Dermatol; 2000; 10(7):528-32. PubMed ID: 11056423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrolimus ointment is effective for facial and intertriginous psoriasis.
    Lebwohl M; Freeman AK; Chapman MS; Feldman SR; Hartle JE; Henning A;
    J Am Acad Dermatol; 2004 Nov; 51(5):723-30. PubMed ID: 15523350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacalcitol ointment in the treatment of psoriasis vulgaris: a multicentre, placebo-controlled, double-blind study on efficacy and safety.
    Van de Kerkhof PC; Werfel T; Haustein UF; Luger T; Czarnetzki BM; Niemann R; Plänitz-Stenzel V
    Br J Dermatol; 1996 Nov; 135(5):758-65. PubMed ID: 8977677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacalcitol ointment for the treatment of nail psoriasis.
    Márquez Balbás G; Sánchez Regaña M; Umbert Millet P
    J Dermatolog Treat; 2009; 20(5):308-10. PubMed ID: 19367480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcitriol ointment and clobetasol propionate cream: a new regimen for the treatment of plaque psoriasis.
    Lahfa M; Mrowietz U; Koenig M; Simon JC
    Eur J Dermatol; 2003; 13(3):261-5. PubMed ID: 12804986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daily versus intermittent application of high-concentration tacalcitol ointment in combination with low-dose cyclosporin for psoriasis vulgaris.
    Abe M; Syuto T; Hasegawa M; Sogabe Y; Yokoyama Y; Ishikawa O
    J Dermatol; 2006 Feb; 33(2):108-11. PubMed ID: 16556277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of cutaneous tolerance and efficacy of calcitriol 3 microg g(-1) ointment and tacrolimus 0.3 mg g(-1) ointment in chronic plaque psoriasis involving facial or genitofemoral areas: a double-blind, randomized controlled trial.
    Liao YH; Chiu HC; Tseng YS; Tsai TF
    Br J Dermatol; 2007 Nov; 157(5):1005-12. PubMed ID: 17935517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limited application of fluticasone propionate ointment, 0.005% in patients with psoriasis of the face and intertriginous areas.
    Lebwohl MG; Tan MH; Meador SL; Singer G
    J Am Acad Dermatol; 2001 Jan; 44(1):77-82. PubMed ID: 11148481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of scalp psoriasis. An effective and safe tacalcitol emulsion].
    Ruzicka T; Trompke C
    Hautarzt; 2004 Feb; 55(2):165-70. PubMed ID: 14968327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of topical tacalcitol efficacy in extending the remission period between nb-UVB phototherapy cycles in psoriatic patients.
    Prignano F; Buggiani G; Lotti T
    Acta Biomed; 2009 Apr; 80(1):51-6. PubMed ID: 19705621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrolimus ointment is effective for psoriasis on the face and intertriginous areas in pediatric patients.
    Brune A; Miller DW; Lin P; Cotrim-Russi D; Paller AS
    Pediatr Dermatol; 2007; 24(1):76-80. PubMed ID: 17300658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Open trial of topical tacalcitol [1 alpha 24(OH)2D3] and solar irradiation for vitiligo vulgaris: upregulation of c-Kit mRNA by cultured melanocytes.
    Katayama I; Ashida M; Maeda A; Eishi K; Murota H; Bae SJ
    Eur J Dermatol; 2003; 13(4):372-6. PubMed ID: 12948918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical tacrolimus for the treatment of psoriasis on the face, genitalia, intertriginous areas and corporal plaques.
    Martín Ezquerra G; Sánchez Regaña M; Herrera Acosta E; Umbert Millet P
    J Drugs Dermatol; 2006 Apr; 5(4):334-6. PubMed ID: 16673800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.